Detalles de la búsqueda
1.
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system.
Cancer
; 129(20): 3326-3333, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389814
2.
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Lancet Oncol
; 21(10): 1331-1340, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002437
3.
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial.
Histopathology
; 77(2): 284-292, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32285460
4.
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Lancet Oncol
; 20(2): 267-281, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579763
5.
Using Online Meeting Software to Facilitate Geographically Dispersed Focus Groups for Health Workforce Research.
Qual Health Res
; 28(10): 1621-1628, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29911490
6.
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol
; 18(9): 1192-1201, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760403
7.
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol
; 17(6): 727-737, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27155740
8.
Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.
BMC Cancer
; 16: 637, 2016 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530156
9.
Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: a randomised controlled trial.
BJU Int
; 115 Suppl 5: 35-45, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25828172
10.
Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years.
Med J Aust
; 202(3): 153-5, 2015 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25669479
11.
Effective and well tolerated: where do these drugs fit now?
Lancet Oncol
; 20(4): 469-470, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770292
12.
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Lancet Oncol
; 15(10): 1076-89, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130995
13.
The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD)--where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial.
BJU Int
; 114 Suppl 1: 9-12, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25047091
14.
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
BJU Int
; 113 Suppl 2: 7-12, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24894850
15.
Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer.
BJU Int
; 114(3): 344-53, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24512527
16.
Cognitive Existential Couple Therapy for newly diagnosed prostate cancer patients and their partners: a descriptive pilot study.
Psychooncology
; 22(2): 465-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21990204
17.
Timing of androgen-deprivation therapy in prostate cancer - Author's reply.
Lancet Oncol
; 18(11): e635, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29208389
18.
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Lancet Oncol
; 13(12): 1260-70, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23151431
19.
Overcoming uncertainty: A framework to guide the implementation of Australian radiation therapy advanced practitioners.
J Med Radiat Sci
; 70(4): 406-416, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526324
20.
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go - Authors' reply.
Lancet Oncol
; 17(8): e313-e314, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511148